Sun Pharma Ordered to Halt Eye Drug Output at Assam Plant
Drug regulators cited quality management failures and restricted manufacture, sale and distribution of ophthalmic products at the Assam facility.
Related stories
China Says Both Sides Discussed Reciprocal Tariff Cuts Worth $30 Billion Each
China’s Commerce Ministry said the sides discussed tariffs, reciprocal tariff cuts worth $30 billion on each side, agricultural trade and other issues.
L impact | REGULATION | Nov 14, 2026, 06:56 AM UTC
China to Add Pfizer GLP-1 Drug to State Health Insurance Scheme
M impact | REGULATION | Nov 14, 2026, 06:02 AM UTC
China to Add JW Therapeutics’ CAR-T Therapy to State Insurance
China’s National Healthcare Security Administration says JW Therapeutics’ CAR-T therapy will be added to the state-run health insurance scheme.
L impact | REGULATION | Nov 14, 2026, 03:03 AM UTC
China to Add JW Therapeutics CAR-T Therapy to State Health Insurance
China's National Healthcare Security Administration says JW Therapeutics' CAR-T therapy will be added to the state-run health insurance scheme.
M impact | REGULATION | Nov 14, 2026, 03:03 AM UTC
Trump Administration Seeks $50 Billion for Air Traffic Control After Outage
The administration boosted its request for air traffic control funding to $50 billion after a communications issue forced a nationwide groundstop, halting thousands of flights for
M impact | REGULATION | Nov 14, 2026, 02:44 AM UTC
Democratic Senators Order Musk to Preserve SpaceX Records Over Ukraine Starlink Access
The Wall Street Journal reports that Democratic senators ordered Musk to preserve SpaceX records concerning Ukraine's access to Starlink.
L impact | REGULATION | Nov 14, 2026, 12:16 AM UTC